Author:
White Michelle K.,Maher Stephen M.,Rizio Avery A.,Bjorner Jakob B.
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference41 articles.
1. U.S. Department of Health and Human Services, Food and Drug Administration (2009). Guidance for industry patient-reported outcome measures: Use in medical product development to support labeling claims.
https://www.fda.gov/downloads/drugs/guidances/ucm193282.pdf
.
2. Coons, S. J., Gwaltney, C. J., Hays, R. D., Lundy, J. J., Sloan, J. A., Revicki, D. A., et al. (2009). Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO good research practices task force report. Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research.
https://doi.org/10.1111/j.1524-4733.2008.00470.x
.
3. Eremenco, S., Coons, S. J., Paty, J., Coyne, K., Bennett, A. V., & McEntegart, D. (2014). PRO data collection in clinical trials using mixed modes: Report of the ISPOR PRO mixed modes good research practices task force. Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research.
https://doi.org/10.1016/j.jval.2014.06.005
.
4. Lee, P. (2014). The future of patient-centric clinical research. Presentation at PRO & eCOA Congress, June 3–15. Spain: Barcelona.
5. Leidy, N. K., & Vernon, M. (2008). Perspectives on patient-reported outcomes: Content validity and qualitative research in a changing clinical trial environment. PharmacoEconomics, 26(5), 363–370.
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献